How should an investor representative to the board of a portfolio company react if he learns that this company was sold without the knowledge of the board? This is the question the “hero” of the case has to answer. Should his organization just “take the money and run” or did he have a responsibility to represent some broader principles?
Stakeholders and Strategy - Brain Circuits
Summary
Leaders are often unaware of their value-critical stakeholders, inhibiting progress on strategic issues. The solution is to get rid of free riders and predators and build more involvement in the value-creation cycle by the stakeholders that matter...
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Repairing reputational damage: don’t go the way of Boeing
Summary
All organizations should have a plan to secure trust during, after (and even before) a crisis hits. Here are a host of examples, good and bad, to learn from.
Contact
Research Information & Knowledge Hub for additional information on IMD publications
The price of innovation: Will Medacta compromise its DNA by embracing robotics?
Summary
Medacta Group SA is a rising star in the orthopedics market, achieving global success through innovative products and techniques, with a particular emphasis on minimally invasive techniques that bring meaningful value to its patients. With its approaches such as Anterior Minimally Invasive Surgery (AMIS) for hip replacement and Kinematic Alignment for knees, Medacta offers high-quality techniques, supporting tools and cutting-edge implants. It also offers personalized surgeon education through the Medacta Orthopedic Research and Education (M.O.R.E.) Institute. Medacta is situated in an evolving landscape, with competitors including Stryker and Zimmer Biomet investing heavily in robotic technologies. Technological advances are being made in data-driven planning tools – including augmented reality – and research institutes are looking for the most advanced solutions as demanded by many hospitals and surgeons. Despite these trends in the industry, Medacta's CEO, Francesco Siccardi has concerns regarding the value of existing robotic systems, noting their lack of proven benefits in patient outcomes or cost reductions, especially in a context of increasing emphasis on value-based care and sustainability. The case explores the opportunities and challenges confronting Medacta as they decide whether to enter the orthopedic robotics market. The company wants to continue to differentiate itself and drive growth in line with its foundational principles of patient care, operational excellence and sustainable innovation. Today, Francesco faces a critical decision around whether now is the time to enter the robotics market and, if so, how Medacta should do so to preserve its culture and stay true to its DNA.
Reference
IMD-2663
Copyright
©2025
Copyright owner
IMD Copyright
Organization
Medacta Group
Industry
Healthcare, Medical Device
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Strategy Meets Execution - Supply Chain
Summary
10 years of exclusive surveys reveal top supply chain strategy challenges—and how tools like AI, ML, and digital twins are reshaping the path forward.
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Fakery and Falsehood - Prevention is Better Than Cure
Summary
It’s possible to immunize people against false or manipulated information through simple exercises that policymakers and platforms could easily roll out.
Contact
Research Information & Knowledge Hub for additional information on IMD publications
How to build strategic agility with an intelligent organizational sensory system
Summary
In today’s fast-paced business environment, an intelligent organizational sensory system is your key to staying ahead. This system integrates tools, processes, and practices to monitor your environment, capture signals of change, and turn them int...
Contact
Research Information & Knowledge Hub for additional information on IMD publications
How the EU can boost its sluggish competitiveness
Summary
The European Commission is once again focused on boosting Europe’s competitiveness, this time by integrating the bloc’s capital markets. The EU executive published a range of measures on March 19, aimed at unlocking the €11.6 trillion ($12.8 trill...
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Renchérissement de notre système de santé: Trois idées pour freiner l’explosion des coûts
Summary
The costs of the Swiss healthcare system are rapidly approaching the 100 billion franc mark per year. On November 24, Switzerland approved the reform of the uniform financing of healthcare (EFAS), with potential savings of 440 million francs per y...
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Are you using disequilibrium to capture the value of digital tools?
Summary
Michael R Wade gets tips on driving transformation at scale from Hamilton Mann, a top executive at leading French aerospace, defense, and cybersecurity company Thales.
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Your company (and your life) in the hands of an AI agent?
Summary
The case study introduces an original way of exploring the many questions and concerns around AI adoption in business. Based on a true story, it discusses the dilemma of AI implementation through Joe, the CIO of ParcelFlow. Joe is getting ready to...
Reference
IMD-2666
Copyright
©2025
Copyright owner
IMD Copyright
Industry
Healthcare, Medical Device;Healthcare, Pharmaceuticals
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications